According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is 1,09ย โฌ. In 2021 the company made an earnings per share (EPS) of 0,03572ย โฌ an increase over its 2020 EPS that were of -7,06ย โฌ.